Solve-RD is a Horizon2020-funded project, dedicated to 'solve the unsolved rare diseases'. European Reference Networks (ERNs) are the European clinical expertise centers for rare diseases [...]

SAVE THE DATES FOR IMPORTANT EpiCARE ACTIVITIES TO COME   December 16th afternoon - 19th (midday), 2021: EpiCARE brainstorming face-to-face workshop in Rome, Italy  (a follow-up [...]

It is our pleasure to share with all of you the report of a survey on Epilepsy and Pregnancy recently diffused by the International Bureau [...]

  Thanks to a funding for the CEF Telecom programme, and a co-funding by the European Agency INEA, we are proud to present 5 e-learning [...]

A webinar about ERNs and Norway’s role on the international arena of rare disorders This webinar took place on June 18th 2021, 10am 2pm In [...]

We are glad to announce that Alexis Arzimanoglou, coordinator of EpiCARE, and Nicola Specchio, estimed member of EpiCARE, have been elected as members of the International League Against [...]

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex. Read the PDF document here. [...]

The 2022 registration is now open The Master in Epileptology organised by the ERN EpiCARE centre Hospital San Juan de Dios – Hospital Clinic, in collaboration [...]

The 33eENE will have as a transversal theme: the advances in the last 10 years in the several areas of epilepsy, taking place on 12 and 13 March, maintaining the already usual satellite symposia and conversations with the specialists of the IF responsibility.

Unfortunately the 2021 EpiCARE annual meeting had to be virtual. To facilitate interaction and quality of attendance the Steering Committee privileged splitting it into [...]